Literature DB >> 21164077

High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells.

Seema Dangwal1, Bernhard H Rauch, Thomas Gensch, Luru Dai, Ellen Bretschneider, Christina Francisca Vogelaar, Karsten Schrör, Anke C Rosenkranz.   

Abstract

OBJECTIVE: Diabetes is associated with vascular remodeling and increased thrombin generation. Thrombin promotes vascular smooth muscle cell (SMC) mitogenesis and migration via protease-activated receptors (PAR)-1, PAR-3, and PAR-4. We investigated the effect of high glucose on expression and function of vascular thrombin receptors. METHODS AND
RESULTS: In human vascular SMCs, high glucose (25 versus 5.5 mmol/L) induced a rapid and sustained increase in PAR-4 mRNA, protein, and cell surface expression. PAR-1 and PAR-3 expression were not changed. High glucose pretreatment (48 hours) enhanced thrombin or PAR-4-activating peptide but not PAR-1-activating peptide evoked intracellular calcium mobilization, migration, and tumor necrosis factor α gene expression. This enhancement of thrombin-stimulated migration and gene expression by high glucose was abolished by endogenous PAR-4 knockdown. PAR-4 regulation was prevented by inhibition of protein kinase (PK)C-β and -δ isoforms or nuclear factor (NF)κB. Nuclear translocation of NFκB in high glucose-stimulated SMCs led to PKC-dependent NFκB binding to the PAR-4 promoter in a chromatin immunoprecipitation assay. Furthermore, in situ hybridization and immunohistochemistry confirmed high abundance of PAR-4 in human diabetic vessels as compared with nondiabetic vessels.
CONCLUSIONS: High glucose enhances SMC responsiveness to thrombin through transcriptional upregulation of PAR-4, mediated via PKC-β, -δ, and NFκB. This may play an important role in the vascular complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164077     DOI: 10.1161/ATVBAHA.110.219105

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  Mapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4.

Authors:  María de la Fuente; Daniel N Noble; Sheetal Verma; Marvin T Nieman
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

Review 2.  Protease-activated receptors in hemostasis.

Authors:  Marvin T Nieman
Journal:  Blood       Date:  2016-04-28       Impact factor: 22.113

3.  Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4).

Authors:  Michele M Mumaw; Maria de la Fuente; Amal Arachiche; James K Wahl; Marvin T Nieman
Journal:  Thromb Res       Date:  2015-04-09       Impact factor: 3.944

4.  Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.

Authors:  Anke C Fender; Sonja Kleeschulte; Svenja Stolte; Katja Leineweber; Markus Kamler; Johannes Bode; Na Li; Dobromir Dobrev
Journal:  Basic Res Cardiol       Date:  2020-01-07       Impact factor: 17.165

Review 5.  Thrombin and vascular inflammation.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  Mol Cell Biochem       Date:  2011-08-23       Impact factor: 3.396

6.  Predictive Value of Fasting Blood Glucose for Microvascular Obstruction in Nondiabetic Patients with ST-Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention.

Authors:  Han Wu; Ran Li; Kun Wang; Dan Mu; Jian-Zhou Chen; Xuan Wei; Xue Bao; Zhong-Hai Wei; Jun Xie; Biao Xu
Journal:  Cardiol Res Pract       Date:  2020-09-26       Impact factor: 1.866

7.  Interleukin-1β increased the expression of protease-activated receptor 4 mRNA and protein in dorsal root ganglion neurons.

Authors:  Zhaojin Wang; Dan Chen; Rui Zhang; Shuhong An; Zaifeng Zhang; Qingyuan Ma
Journal:  Neurochem Res       Date:  2013-06-18       Impact factor: 3.996

8.  PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.

Authors:  Simon J Wilson; Fraz A Ismat; Zhaoqing Wang; Michael Cerra; Hafid Narayan; Jennifer Raftis; Timothy J Gray; Shea Connell; Samira Garonzik; Xuewen Ma; Jing Yang; David E Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-12-21       Impact factor: 8.311

9.  PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes.

Authors:  Alessandra Giannella; Giulio Ceolotto; Claudia Maria Radu; Arianna Cattelan; Elisabetta Iori; Andrea Benetti; Fabrizio Fabris; Paolo Simioni; Angelo Avogaro; Saula Vigili de Kreutzenberg
Journal:  Cardiovasc Diabetol       Date:  2021-04-03       Impact factor: 9.951

10.  Subcellular proteomic approach for identifying the signaling effectors of protein kinase C-β₂ under high glucose conditions in human umbilical vein endothelial cells.

Authors:  Min Zhang; Fang Sun; Fangfang Chen; Bo Zhou; Yaqian Duan; Hong Su; Xuebo Lin
Journal:  Mol Med Rep       Date:  2015-09-30       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.